<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="107632">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01966263</url>
  </required_header>
  <id_info>
    <org_study_id>497</org_study_id>
    <secondary_id>2013-001008-13</secondary_id>
    <secondary_id>NL43965.072.13</secondary_id>
    <nct_id>NCT01966263</nct_id>
  </id_info>
  <brief_title>Fast Track TKA: LIA vs FNB</brief_title>
  <official_title>Fast-track Rehabilitation Protocol for Total Knee Arthroplasty: A Randomized Controlled Trial Comparing Local Infiltration Analgesia With Femoral Nerve Block</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sint Maartenskliniek</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sint Maartenskliniek</source>
  <oversight_info>
    <authority>the Netherlands: Central Committee on Research inv. Human Subjects</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      For an optimal and fast recovery after total knee arthroplasty (TKA), a fast track
      rehabilitation protocol has been developed. The literature is not yet conclusive about the
      optimal anesthestic technique. The optimal technique should support fast mobilization by
      giving good pain relieve with minimal side effects such as nausea, drowsiness and muscle
      weakness. If pain relieve is optimal, the patient mobilizes fast and length of stay is
      shortened. But does fast recovery lead to better functional outcome? The objective of this
      study is to determine whether either a femoral nerve block (FNB) or local infiltration
      analgesia (LIA) is a better anesthetic technique to achieve optimal functional outcome after
      one year in patients receiving a total knee arthroplasty and following a fast track
      rehabilitation protocol.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>November 2013</start_date>
  <primary_completion_date type="Anticipated">October 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Performance Battery consisting of three functional tests</measure>
    <time_frame>one year</time_frame>
    <safety_issue>No</safety_issue>
    <description>The performance battery consists of three functional tests: The Timed Up and Go test (TUG), the Stair Climbing Task (SCT) and the Six Minutes Walk Test (6MWT).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>length of stay</measure>
    <time_frame>3-7 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>duration of hospitalization after the total knee arthroplasty</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time to reach discharge criteria</measure>
    <time_frame>3-7 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>tiem to reach discharge criteria after total knee arthroplasty (in days)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quantity of mobilization during hospitalization</measure>
    <time_frame>3-7 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>quantity of mobilization (walking, standing, stair climbing etc) in hours, during hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain medication consumption</measure>
    <time_frame>during hospital stay; 3, 6 and 12 months postoperatively</time_frame>
    <safety_issue>No</safety_issue>
    <description>consumption of pain medication</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>painscores</measure>
    <time_frame>during hospital stay; 3, 6 and 12 months postoperatively</time_frame>
    <safety_issue>No</safety_issue>
    <description>painscores at rest and during mobilization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>range of motion</measure>
    <time_frame>at hospital discharge (3-7 days postoperative); 3, 6 and 12 months postoperatively</time_frame>
    <safety_issue>No</safety_issue>
    <description>range of motion of the operated knee</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>functional outcome</measure>
    <time_frame>at hospital discharge (3-7 days postoperative); 6 weeks, 3, 6 and 12 months postoperatively</time_frame>
    <safety_issue>No</safety_issue>
    <description>functional outcome reported by the patient (patient-based questionnaires)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fear of motion</measure>
    <time_frame>at hospital discharge (3-7 days postoperative), 6 weeks, 3, 6 and 12 months postoperatively</time_frame>
    <safety_issue>No</safety_issue>
    <description>fear of motion reported by the patient (questionnaire)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of life</measure>
    <time_frame>at hospital discharge(3-7 days postoperative), 6 weeks, 3, 6 and 12 months postoepratively</time_frame>
    <safety_issue>No</safety_issue>
    <description>quality of life by patient-based questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction (Numeric Rating Scale; 0=very dissatisfied, 10=very satisfied)</measure>
    <time_frame>at hospital discharge (3-7 days postoperative)</time_frame>
    <safety_issue>No</safety_issue>
    <description>patient satisfaction (NRS) with analgesia and patient satisfaction (NRS) with fast track rehabilitation protocol</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Arthroplasty, Replacement, Knee</condition>
  <arm_group>
    <arm_group_label>Local Infiltration Analgesia (LIA)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>local infiltration analgesia is an anesthetic technique that consists of the infiltration of operated tissue with a long acting local anesthetic during surgery to achieve postoperative pain relieve. In this study LIA of the knee will exist of: 1. local infiltration analgesie (LIA) of the posterior capsule of the knee, 2. LIA of the anterior capsule of the knee and 3. LIA of the subcutaneous tissue of the knee</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Femoral Nerve Block (FNB)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>a femoral nerve block is an anaesthetic technique that consists of anesthetizing the femoral nerve proximal of the operating area to achieve numbness distal of the block puncture site. A catheter can be placed, so the nerve can be anesthetized continuously or repeatedly for post-operative pain relieve.
In this study the FNB with catheter will be combined with local infiltration analgesie (LIA) of the posterior capsule of the knee</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LIA of the posterior capsule of the knee</intervention_name>
    <description>the surgeon infiltrates the posterior capsule of the knee using 100 mL ropivacaine 0.2% with 0.5 mg epinephrine.</description>
    <arm_group_label>Local Infiltration Analgesia (LIA)</arm_group_label>
    <arm_group_label>Femoral Nerve Block (FNB)</arm_group_label>
    <other_name>Naropin 0.2%</other_name>
    <other_name>Adrenalin 1mg/mL</other_name>
    <other_name>local infiltration analgesia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LIA of the anterior capsule of the knee</intervention_name>
    <description>the surgeon infiltrates the anterior capsule of the knee using 50 mL ropivacaine 0.2% with 0.25 mg epinephrine.</description>
    <arm_group_label>Local Infiltration Analgesia (LIA)</arm_group_label>
    <other_name>Naropin 0.2%</other_name>
    <other_name>Adrenalin 1mg/mL</other_name>
    <other_name>local infiltration analgesia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LIA of the subcutaneous tissue of the knee</intervention_name>
    <description>the surgeon infiltrates the subcutaneous tissue of the knee using 50 mL ropivacaine 0.2% before wound closure.</description>
    <arm_group_label>Local Infiltration Analgesia (LIA)</arm_group_label>
    <other_name>Naropin 0.2%</other_name>
    <other_name>local infiltration analgesia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>FNB with catheter</intervention_name>
    <description>pre-operatively the anesthesiologist will ultrasound guided place a catheter close to the femoral nerve using NaCl 0.9% (no local anesthetic). During surgery, when the LIA of the posterior capsule is performed, 20 mL ropivacaine 0.2% will be administered through the catheter to create a femoral nerve block (FNB). Postoperatively patients will receive 20 mL ropivacaine 0.2% through the catheter 6 times daily for 24 hours</description>
    <arm_group_label>Femoral Nerve Block (FNB)</arm_group_label>
    <other_name>Naropin 0.2%</other_name>
    <other_name>normal saline</other_name>
    <other_name>femoral nerve block</other_name>
    <other_name>continuous femoral nerve block</other_name>
    <other_name>femoral catheter</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA physical health status I-II

          -  patient presents with non-inflammatory primary knee osteoarthritis (radiological
             confirmation)

          -  patient is planned for a primary unilateral posterior-stabilized tri-compartmental
             cemented total knee replacement (Genesis II - PS)

          -  patient is scheduled for fast track protocol

          -  patient plans to be available fot follow-up through one year post-operative

          -  written informed consent

        Exclusion Criteria:

          -  any contra-indication for locoregional anesthesia

          -  any contra-indication for spinal anesthesia

          -  traumatic osteoarthritis requiring TKA

          -  an active, local infection or systemic infection

          -  known hypersensitivity to amide-type local anesthetics

          -  known intolerance or contraindication for opioids, NSAIDs or paracetamol

          -  a Body Mass Index &gt; 40 kg/m2

          -  inability to walk independently (inability to walk at least 10 consecutive meters
             without a walking aid)

          -  scheduled for contralateral TKA within one year postoperative

          -  scheduled for another operation within 3 months postoperative

          -  physical, emotional or neurological conditions that would compromize compliance with
             postoperative rehabilitation and follow-up

          -  chronic opioid analgesic therapy

          -  chronic gabapentin or pregabalin analgesic therapy

          -  rheumatoid arthritis
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rudolf Stienstra, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sint Maartenskliniek</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rudolf Stienstra, MD, PhD</last_name>
    <phone>+31 (0)24 365 9085</phone>
    <email>r.stienstra@maartenskliniek.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maaike Fenten, MD</last_name>
    <phone>+31 (0)24 365 9935</phone>
    <email>m.fenten@maartenskliniek.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sint Maartenskliniek</name>
      <address>
        <city>Ubbergen</city>
        <zip>6574NA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rudolf Stienstra, MD, PhD</last_name>
      <phone>+31 (0)24 365 9085</phone>
      <email>r.stienstra@maartenskliniek.nl</email>
    </contact>
    <contact_backup>
      <last_name>Maaike Fenten, MD</last_name>
      <phone>+31 (0)24 365 9935</phone>
      <email>m.fenten@maartenskliniek.nl</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 16, 2013</lastchanged_date>
  <firstreceived_date>October 11, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sint Maartenskliniek</investigator_affiliation>
    <investigator_full_name>Rudolf Stienstra</investigator_full_name>
    <investigator_title>Anesthesiologist, Head of anesthesiology department</investigator_title>
  </responsible_party>
  <keyword>total knee arthroplasty</keyword>
  <keyword>femoral nerve block</keyword>
  <keyword>local infiltration analgesia</keyword>
  <keyword>fast track</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
